| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.48 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |